Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 9/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CMA1 | P23946 | 5/20 | 0.36 |
| ▸ | CTRC | Q99895 | 2/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8203250 | 0.92 | F2 (0.41) | F2PRSS1ITGB3ITGA2BCMA1 | |
| SCHEMBL13435877 | 0.91 | F2 (0.43) | F2PRSS1ITGB3ITGA2BCMA1 | |
| SCHEMBL6383995 | 0.88 | ITGB3 (0.39) | F2PRSS1ITGB3ITGA2BMEN1 | |
| SCHEMBL12831724 | 0.87 | F2 (0.39) | F2PRSS1ITGB3ITGA2BMEN1 | |
| SCHEMBL13436020 | 0.85 | ITGB3 (0.40) | F2PRSS1ITGB3ITGA2BMEN1 | |
| SCHEMBL6124816 | 0.82 | F2 (0.44) | F2PRSS1ITGB3ITGA2BCMA1 | |
| SCHEMBL7941871 | 0.81 | HDAC1 (0.35) | F2PRSS1ITGB3ITGA2BMEN1 | |
| SCHEMBL6124828 | 0.81 | HDAC1 (0.35) | F2PRSS1ITGB3ITGA2BMEN1 | |
| SCHEMBL13436021 | 0.81 | F2 (0.43) | F2PRSS1ITGB3ITGA2BCMA1 | |
| SCHEMBL12831782 | 0.80 | ITGB3 (0.40) | F2PRSS1ITGB3ITGA2BCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2177523-A1 | Novel macrocyclic inhibitors of hepatitis c virus replication | Intermune, Inc. (US) | 2010-04-21 | — | — | EP | disclosed |